17(18)-EpETE

17(18)-epete is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 82 references associated with 17(18)-EpETE in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 17(18)-EpETE

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 17(18)-EpETE

All references with 17(18)-EpETE

Download all related citations
Per page 10 20 | Total 18
Authors Title Published Journal PubMed Link
Kubota T et al. Eicosapentaenoic acid is converted via ω-3 epoxygenation to the anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid. 2014 FASEB J. pmid:24128889
Yanai R et al. Cytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularization. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24979774
Brahmbhatt V et al. Protective effects of dietary EPA and DHA on ischemia-reperfusion-induced intestinal stress. 2013 J. Nutr. Biochem. pmid:22819560
Morin C et al. Bronchial inflammation induced PKCζ over-expression: involvement in mechanical properties of airway smooth muscle. 2012 Can. J. Physiol. Pharmacol. pmid:22324796
Falck JR et al. 17(R),18(S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues. 2011 J. Med. Chem. pmid:21591683
Schmelzle M et al. Cardioprotection of 17,18-epoxyeicostetraenoic acid in ischemia/reperfusion is mediated by cyclooxygenase-2: a study in a rat model. 2011 Transplant. Proc. pmid:21693227
Morin C et al. 17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase. 2010 Am. J. Respir. Cell Mol. Biol. pmid:20008283
Morin C et al. Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung. 2009 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:18978038
Hercule HC et al. The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK alpha channel subunit in rodents. 2007 Exp. Physiol. pmid:17675416
Schwarz D et al. Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns. 2005 Biochem. Biophys. Res. Commun. pmid:16153604

Table of Content